tiprankstipranks
Protagonist expects to reach VERIFY enrollment target by end of March
PremiumThe FlyProtagonist expects to reach VERIFY enrollment target by end of March
4M ago
Protagonist closes rusfertide license, collaboration agreement with Takeda
PremiumThe Fly
Protagonist closes rusfertide license, collaboration agreement with Takeda
4M ago
Protagonist Therapeutics announces presentation of data on JNJ-2113
PremiumThe Fly
Protagonist Therapeutics announces presentation of data on JNJ-2113
4M ago
3 Best Stocks to Buy Now, 1/29/2024, According to Top Analysts 
PremiumStock Analysis & Ideas3 Best Stocks to Buy Now, 1/29/2024, According to Top Analysts 
6M ago
Capital One says buy these six biotech stocks for 2024
PremiumThe Fly
Capital One says buy these six biotech stocks for 2024
6M ago
Capital One says buy these six biotech stocks for 2024
PremiumThe Fly
Capital One says buy these six biotech stocks for 2024
6M ago
Protagonist Therapeutics initiated with an Overweight at Capital One
PremiumThe FlyProtagonist Therapeutics initiated with an Overweight at Capital One
9M ago
Protagonist Therapeutics announces advancement of JNJ-2113 across indications
PremiumThe Fly
Protagonist Therapeutics announces advancement of JNJ-2113 across indications
10M ago
Protagonist Therapeutics price target lowered to $34 from $36 at JPMorgan
PremiumThe Fly
Protagonist Therapeutics price target lowered to $34 from $36 at JPMorgan
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100